208 related articles for article (PubMed ID: 24564241)
21. Identifying significant pathways of hepatitis B virus-related hepatocellular carcinoma based on crosstalk and network pathways.
Wen LM; Wu WZ; Peng XC
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420970
[TBL] [Abstract][Full Text] [Related]
22. Network analysis of HBV‑ and HCV‑induced hepatocellular carcinoma based on Random Forest and Monte Carlo cross‑validation.
Zhao SN; Liu LL; Lv ZP; Wang XH; Wang CH
Mol Med Rep; 2017 Sep; 16(3):2411-2416. PubMed ID: 28656273
[TBL] [Abstract][Full Text] [Related]
23. Identification of hepatocellular carcinoma-related genes with a machine learning and network analysis.
Gui T; Dong X; Li R; Li Y; Wang Z
J Comput Biol; 2015 Jan; 22(1):63-71. PubMed ID: 25247452
[TBL] [Abstract][Full Text] [Related]
24. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.
Zheng S; Tansey WP; Hiebert SW; Zhao Z
BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427
[TBL] [Abstract][Full Text] [Related]
25. Investigation of key microRNAs associated with hepatocellular carcinoma using small RNA-seq data.
Lin LJ; Lin Y; Jin Y; Zheng CQ
Mol Biol Rep; 2014 Jul; 41(7):4341-9. PubMed ID: 24623406
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
27. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA.
Zhang J; Fan J; Zhou C; Qi Y
BMC Gastroenterol; 2017 Jun; 17(1):81. PubMed ID: 28637446
[TBL] [Abstract][Full Text] [Related]
28. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
29. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
30. Dynamic protein interaction modules in human hepatocellular carcinoma progression.
Yu H; Lin CC; Li YY; Zhao Z
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S2. PubMed ID: 24564909
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
[TBL] [Abstract][Full Text] [Related]
32. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
Liu T; Wu H; Qi J; Qin C; Zhu Q
Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
[TBL] [Abstract][Full Text] [Related]
34. Key genes associated with diabetes mellitus and hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Pathol Res Pract; 2019 Nov; 215(11):152510. PubMed ID: 31591054
[TBL] [Abstract][Full Text] [Related]
35. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
37. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
38. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Norton PA; Mehta AS
World J Gastroenterol; 2019 Jun; 25(23):2947-2960. PubMed ID: 31249452
[TBL] [Abstract][Full Text] [Related]
39. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
40. Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma.
Mei J; Yang X; Xia D; Zhou W; Gu D; Wang H; Liu C
Mol Genet Genomic Med; 2020 Sep; 8(9):e1384. PubMed ID: 32588988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
